CLK1 and arthritic joint disease: This, combined with the previously shown fact that CLK inhibitors seem to also reduce inflammatory processes, highlights CLK inhibition as a promising approach in the treatment of diseases that depend on angiogenesis and inflammation, such as arthritis and wAMD.